News

Nature
nature.com > collections > iiiddbahja

Towards generative biology: concepts and methods for AI-enhanced synthetic biology

2+ hour, 47+ min ago  (472+ words) Nature Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet…...

Silicon Republic
siliconrepublic.com > innovation > coded-cells-redefining-research-drug-discovery-leadership-skills

The Coded cells redefining research and drug discovery

16+ hour, 58+ min ago  (1009+ words) Dr Emma Pepperell. Image: Bit.Bio Bit.Bio’s Dr Emma Pepperell discusses her career in the biotechnology sector, the advancements occurring around her and the importance of bringing a touch of humanity to an often clinical industry. Interested in veterinary…...

Grit Daily News
gritdaily.com > the-early-chemistry-decisions-that-make-protein-degraders-developable

The Early Chemistry Decisions That Make Protein Degraders Developable

6+ hour, 6+ min ago  (661+ words) How a degrader is designed in its first weeks of discovery decides whether it ever reaches a development-stage candidate. In 2026, the FDA approved the first proteolysis targeting chimera (PROTAC) therapeutic to reach patients, more than two decades after induced proximity…...

BIOENGINEER.ORG
bioengineer.org > insilico-medicine-bora-pharmaceuticals-partner-on-ai-drug-discovery-and-development

Insilico Medicine, Bora Pharmaceuticals partner on AI drug discovery and

3+ hour, 12+ min ago  (327+ words) Insilico Medicine, a clinical-stage generative AI drug discovery company, has announced a multi-target strategic alliance with Bora Pharmaceuticals, a global pharmaceutical manufacturing leader. The collaboration, disclosed on July 15, 2026, is structured around definitive agreements that will define scope, governance, and execution....

Whalesbook
whalesbook.com > news > English > healthcarebiotech > OpenAI-Researcher-Plans-dollar2B-AI-Drug-Discovery-Startup > 6a56d4595cb7edf90c2fc938

OpenAI Researcher Plans $2B AI Drug Discovery Startup

3+ hour, 30+ min ago  (268+ words) Whalesbook Miles Wang, a researcher previously associated with OpenAI’s initiatives in scientific discovery, is set to launch a new venture aimed at using artificial intelligence to modernize drug discovery Reports indicate that the startup is in early discussions to…...

Google News
nature.com > articles > s41589-026-02254-6

Early maturation of host antimicrobial peptide defences is associated with host–pathogen coexistence | Nature Chemical Biology

9+ hour, 29+ min ago  (1728+ words) Nature Chemical Biology (2026) Cite this article a, Proportion of deceased postmetamorphic individuals (Ibón de Acherito, n = 7; Lac d’Arlet, n = 17; Lac d’Lhurs, n = 0; Puits d’Arious, n = 3) from total encountered (Ibón de Acherito, N = 47; Lac d’Arlet, N = 26; Lac d’Lhurs, N = 40; Puits d’Arious,…...

The Tech Buzz
techbuzz.ai > articles > openai-researcher-miles-wang-eyes-2b-ai-drug-discovery-startup

OpenAI Researcher Miles Wang Eyes $2B AI Drug Discovery Startup

9+ hour, 44+ min ago  (921+ words) The Tech Buzz OpenAI Researcher Miles Wang Eyes $2B AI Drug Discovery Startup Miles Wang leaving OpenAI to launch AI biotech venture with Lightspeed backing OpenAI researcher Miles Wang is in advanced talks to spin out and launch an AI-powered drug…...

@ASBMB
asbmb.org > asbmb-today > policy > 071526 > americas-biomedical-future-depends-on-the-nih

America’s biomedical future depends on the NIH

10+ hour, 14+ min ago  (533+ words) Americans should celebrate this country’s extraordinary achievements over nearly 250 years. As a biomedical scientist, I am especially proud of discoveries that have transformed medicine, extended lives, created industries and trained generations of scientists. That is why Scott Atlas’s call to…...

HIT Consultant
hitconsultant.net > 07/14/2026 > chai-discovery-raises-400-million-series-c

Chai Discovery Raises $400M to Accelerate AI-Driven Molecular Design Platform

22+ hour, 52+ min ago  (280+ words) HIT Consultant What You Should Know - Structural biology and AI drug design pioneer Chai Discovery has announced a $400M Series C funding round, valuing the company at $3.8 billion just two years after its 2024 founding. - The heavily oversubscribed round was led by…...

Weddings
weddings.lavenderhotels.co.uk > 3-8-billion-molecular-mirage-vcs-pouring-hundreds-millions-ai-drug

The $3.8 Billion Molecular Mirage Why VCs Are Pouring Hundre — Weddings

17+ hour, 19+ min ago  (432+ words) Chai Discovery, founded in 2024 by a team of alumni from OpenAI, Meta FAIR, and Stripe, wants to treat biology as an engineering problem instead of a lottery. Their software attempts to predict, reprogram, and design biological structures from scratch. To…...